Developing a SARS-CoV-2 Antigen Test Using Engineered Affinity Proteins
- PMID: 34379400
- DOI: 10.1021/acsami.1c08174
Developing a SARS-CoV-2 Antigen Test Using Engineered Affinity Proteins
Abstract
The ongoing COVID-19 pandemic has clearly established how vital rapid, widely accessible diagnostic tests are in controlling infectious diseases and how difficult and slow it is to scale existing technologies. Here, we demonstrate the use of the rapid affinity pair identification via directed selection (RAPIDS) method to discover multiple affinity pairs for SARS-CoV-2 nucleocapsid protein (N-protein), a biomarker of COVID-19, from in vitro libraries in 10 weeks. The pair with the highest biomarker sensitivity was then integrated into a 10 min, vertical-flow cellulose paper test. Notably, the as-identified affinity proteins were compatible with a roll-to-roll printing process for large-scale manufacturing of tests. The test achieved 40 and 80 pM limits of detection in 1× phosphate-buffered saline (mock swab) and saliva matrices spiked with cell-culture-generated SARS-CoV-2 viruses and is also capable of detection of N-protein from characterized clinical swab samples. Hence, this work paves the way toward the mass production of cellulose paper-based assays which can address the shortages faced due to dependence on nitrocellulose and current manufacturing techniques. Further, the results reported herein indicate the promise of RAPIDS and engineered binder proteins for the timely and flexible development of clinically relevant diagnostic tests in response to emerging infectious diseases.
Keywords: affinity protein; cellulose; enzyme-linked immunosorbent assays; library screening; peptides and proteins.
Update of
-
Developing a SARS-CoV-2 Antigen Test Using Engineered Affinity Proteins.ChemRxiv [Preprint]. 2021 Apr 19. doi: 10.26434/chemrxiv.14442785. ChemRxiv. 2021. Update in: ACS Appl Mater Interfaces. 2021 Aug 25;13(33):38990-39002. doi: 10.1021/acsami.1c08174. PMID: 34013166 Free PMC article. Updated. Preprint.
Similar articles
-
Developing a SARS-CoV-2 Antigen Test Using Engineered Affinity Proteins.ChemRxiv [Preprint]. 2021 Apr 19. doi: 10.26434/chemrxiv.14442785. ChemRxiv. 2021. Update in: ACS Appl Mater Interfaces. 2021 Aug 25;13(33):38990-39002. doi: 10.1021/acsami.1c08174. PMID: 34013166 Free PMC article. Updated. Preprint.
-
Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.Virol J. 2021 Mar 9;18(1):52. doi: 10.1186/s12985-021-01530-2. Virol J. 2021. PMID: 33750394 Free PMC article.
-
Evaluation of Lumipulse® G SARS-CoV-2 antigen assay automated test for detecting SARS-CoV-2 nucleocapsid protein (NP) in nasopharyngeal swabs for community and population screening.Int J Infect Dis. 2021 Apr;105:391-396. doi: 10.1016/j.ijid.2021.02.098. Epub 2021 Feb 26. Int J Infect Dis. 2021. PMID: 33647511 Free PMC article.
-
Rapid diagnosis of SARS-CoV-2 using potential point-of-care electrochemical immunosensor: Toward the future prospects.Int Rev Immunol. 2021;40(1-2):126-142. doi: 10.1080/08830185.2021.1872566. Epub 2021 Jan 15. Int Rev Immunol. 2021. PMID: 33448909 Review.
-
Molecular Diagnostic Tools for the Detection of SARS-CoV-2.Int Rev Immunol. 2021;40(1-2):143-156. doi: 10.1080/08830185.2020.1871477. Epub 2021 Jan 13. Int Rev Immunol. 2021. PMID: 33439059 Review.
Cited by
-
Influenza viruses and SARS-CoV-2 diagnosis via sensitive testing methods in clinical application.Heliyon. 2024 Aug 21;10(18):e36410. doi: 10.1016/j.heliyon.2024.e36410. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39381246 Free PMC article. Review.
-
Backstage Heroes-Yeast in COVID-19 Research.Int J Mol Sci. 2024 Nov 25;25(23):12661. doi: 10.3390/ijms252312661. Int J Mol Sci. 2024. PMID: 39684373 Free PMC article. Review.
-
Nanobody-Functionalized Cellulose for Capturing SARS-CoV-2.Appl Environ Microbiol. 2022 Mar 8;88(5):e0230321. doi: 10.1128/aem.02303-21. Epub 2022 Jan 5. Appl Environ Microbiol. 2022. PMID: 34985974 Free PMC article.
-
A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies.Commun Med (Lond). 2021 Nov 11;1:46. doi: 10.1038/s43856-021-00045-9. eCollection 2021. Commun Med (Lond). 2021. PMID: 35602218 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous